Why is ANG Lifesciences falling/rising?

As of 15-Oct, ANG Lifesciences India Ltd is experiencing a decline in its stock price, currently at 31.40, reflecting a decrease of 0.32 or 1.01%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 6.99% during this period. Additionally, the stock's performance over the past week shows a significant drop of 4.68%, and it has underperformed the sector by 1.09%. The delivery volume has also decreased, with a 38.2% drop compared to the 5-day average, indicating falling investor participation. The stock's returns over various periods highlight a troubling trend, with year-to-date returns down 29.74% and a staggering 78.92% decline over the past three years, suggesting ongoing challenges for the company.
In the broader market context, the Sensex has shown resilience, gaining 1.02% over the past week and 5.72% year-to-date, contrasting sharply with ANG Lifesciences' poor performance. This divergence indicates that while the overall market is experiencing growth, ANG Lifesciences is struggling significantly. The stock's recent performance is not only below the benchmark but also reflects a broader trend of underperformance relative to market indices, further exacerbating investor concerns.